New criteria for automated preschool vision screening

February 4, 2013 in Ophthalmology

The Vision Screening Committee of the American Association for Pediatric Ophthalmology and Strabismus, the professional organization for pediatric eye care, has revised its guidelines for automated preschool vision screening based on new evidence. The new guidelines are published in the February issue of the Journal of AAPOS.

Approximately 2% of children develop amblyopia, sometimes known as "" – a loss of vision in one or both eyes caused by conditions that impair the normal during the period of development of vision. Amblyopia remains treatable until 60 months, with treatment becoming less effective after age 5.

The AAPOS Committee established the first guidelines for automated preschool vision screening in 2003. These primarily addressed the magnitude of that was (by consensus) thought to put a child at risk for the development of amblyopia. Since then, more data have emerged about the prevalence of amblyopia in young children from which it is clear that most children with these risk factors do not develop the condition. Likewise, technology has advanced, and screening instruments are now available that detect abnormalities other than amblyopia risk factors. The Committee has therefore reviewed the new evidence and adjusted its criteria.

"Over the last decade, automated methods for vision screening have progressed to the point where they are now extremely effective in identifying vision problems in children prior to their being able to read an ," said lead author Sean P. Donahue, MD, PhD, of the Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN. "It is exciting to see pediatricians adopt these technologies."

He continued: "If the detection of decreased vision and amblyopia are the goals of screening, then referrals based on technology that detects risk factors will result in over-referrals. It is therefore imperative that updated guidelines for detecting amblyopia risk factors propose levels that best separate those children who are most at risk for developing amblyopia from those who are not."

The Committee's recommendations include:

  • Separate criteria for toddlers (12-30 months), early preschool children (31-48 months), late preschool and kindergarten children (49-72 months), and school-aged children (over 72 months)
  • Lower referral rate for young children by raising the threshold referral values
  • Use of traditional optotype recognition screening option for school-age children who can read linear letters
  • Detection of visually significant media opacities and manifest (not intermittent) at all ages
  • Instruments that detect amblyopia should report results using amblyopia presence as the gold standard
The Committee also noted that the U.S. Preventive Services Task Force (USPSTF) has specifically endorsed the use of photoscreening modalities for the detection of risk factors in the 3- to 5-year-old age group.

Journal of AAPOS Editor-in-Chief Edward G. Buckley, MD, Professor of Ophthalmology and Pediatrics and Vice-Dean of Medical Education at Duke University School of Medicine, commented, "Early detection is critical if we are to be successful in eliminating unnecessary treatable vision loss in children. These new guidelines hopefully will allow children's health care providers to get one step closer to our goal."

More information: "Guidelines for automated preschool vision screening: A 10-year, evidence-based update," by Sean P. Donahue, MD, PhD, Brian Arthur, MD, Daniel E. Neely, MD, Robert W. Arnold, MD, David Silbert, MD, FAAP, and James B. Ruben, MD, on behalf of the AAPOS Vision Screening Committee, DOI: dx.doi.org/10.1016… .2012.09.012. It appears in the Journal of AAPOS, Volume 17, Issue 1 (February 2013)

Journal reference: Journal of AAPOS search and more info website

Provided by Elsevier search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Glaucoma drug can cause droopy eyelids

Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...

Ophthalmology created 13 hours ago | popularity not rated yet | comments 0

Eyes on the sun: Child sunshine exposure and eye development

(Medical Xpress)—Exposure to sunshine as a small child is crucial to the development of a healthy eye according to results of long-term myopia study conducted by University of Sydney researchers.

Ophthalmology created 18 hours ago | popularity 5 / 5 (1) | comments 0

New study pinpoints biochemical mechanism underlying fibrosis following glaucoma surgery

The most common cause of failure after glaucoma surgery is scarring at the surgical site, so researchers are actively looking for ways to minimize or prevent scar formation. Previous work had suggested that vascular endothelial ...

Ophthalmology created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Early screenings key to diagnosing glaucoma

New research is emphasizing the importance of regular screenings for glaucoma, a disease that deteriorates the optic nerve over time and is a leading cause of irreversible blindness worldwide. The onset of glaucoma is associated ...

Ophthalmology created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

University partners with Sony to find cure for 'lazy eye'

The University of Nottingham and Nottingham University Hospitals NHS Trust, have been working with Sony Computer Entertainment Europe (SCEE) to develop special 3-D glasses and games to help treat children ...

Ophthalmology created May 08, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.